Wogonoside prevents colitis-associated colorectal carcinogenesis and colon cancer progression in inflammation-related microenvironment via inhibiting NF-κB activation through PI3K/Akt pathway
- PMID: 27102438
- PMCID: PMC5085157
- DOI: 10.18632/oncotarget.8815
Wogonoside prevents colitis-associated colorectal carcinogenesis and colon cancer progression in inflammation-related microenvironment via inhibiting NF-κB activation through PI3K/Akt pathway
Abstract
The inflammatory microenvironment has been reported to be correlated with tumor initiation and malignant development. In the previous studies we have found that wogonoside exerts anti-neoplastic and anti-inflammatory activities. In this study, we aimed to further investigate the chemopreventive effects of wogonoside on colitis-associated cancer and delineated the potential mechanisms. In the azoxymethane initiated and dextran sulfate sodium (AOM/DSS) promoted colorectal carcinogenesis mouse model, wogonoside significantly reduced the disease severity, lowered tumor incidence and inhibited the development of colorectal adenomas. Moreover, wogonoside inhibited inflammatory cells infiltration and cancer cell proliferation at tumor site. Furthermore, wogonoside dramatically decreased the secretion and expression of IL-1β, IL-6 and TNF-α as well as the nuclear expression of NF-κB in adenomas and surrounding tissues. In vitro results showed that wogonoside suppressed the proliferation of human colon cancer cells in the inflammatory microenvironment. Mechanistically, we found that wogonoside inhibited NF-κB activation via PI3K/Akt pathway. In conclusion, our results demonstrated that wogonoside attenuated colitis-associated tumorigenesis in mice and inhibited the progression of human colon cancer in inflammation-related microenvironment via suppressing NF-κB activation by PI3K/Akt pathway, indicating that wogonoside could be a promising therapeutic agent for colorectal cancer.
Keywords: AOM/DSS mouse model; NF-κB; colitis-associated cancer; wogonoside.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures






Similar articles
-
Wogonoside protects against dextran sulfate sodium-induced experimental colitis in mice by inhibiting NF-κB and NLRP3 inflammasome activation.Biochem Pharmacol. 2015 Mar 15;94(2):142-54. doi: 10.1016/j.bcp.2015.02.002. Epub 2015 Feb 10. Biochem Pharmacol. 2015. PMID: 25677765
-
Chemopreventive Effect of Aster glehni on Inflammation-Induced Colorectal Carcinogenesis in Mice.Nutrients. 2018 Feb 12;10(2):202. doi: 10.3390/nu10020202. Nutrients. 2018. PMID: 29439531 Free PMC article.
-
NF-κB and Nrf2 signaling pathways contribute to wogonin-mediated inhibition of inflammation-associated colorectal carcinogenesis.Cell Death Dis. 2014 Jun 5;5(6):e1283. doi: 10.1038/cddis.2014.221. Cell Death Dis. 2014. PMID: 24901054 Free PMC article.
-
Baicalein increases cisplatin sensitivity of A549 lung adenocarcinoma cells via PI3K/Akt/NF-κB pathway.Biomed Pharmacother. 2017 Jun;90:677-685. doi: 10.1016/j.biopha.2017.04.001. Epub 2017 Apr 14. Biomed Pharmacother. 2017. PMID: 28415048 Review.
-
NF-kappaB signaling pathway, inflammation and colorectal cancer.Cell Mol Immunol. 2009 Oct;6(5):327-34. doi: 10.1038/cmi.2009.43. Cell Mol Immunol. 2009. PMID: 19887045 Free PMC article. Review.
Cited by
-
Network analysis reveals miRNA crosstalk between periodontitis and oral squamous cell carcinoma.BMC Oral Health. 2023 Jan 13;23(1):19. doi: 10.1186/s12903-022-02704-2. BMC Oral Health. 2023. PMID: 36639776 Free PMC article.
-
Low-dose interleukin-2 alleviates dextran sodium sulfate-induced colitis in mice by recovering intestinal integrity and inhibiting AKT-dependent pathways.Theranostics. 2020 Apr 6;10(11):5048-5063. doi: 10.7150/thno.41534. eCollection 2020. Theranostics. 2020. PMID: 32308767 Free PMC article.
-
Acceleration of pancreatic tumorigenesis under immunosuppressive microenvironment induced by Reg3g overexpression.Cell Death Dis. 2017 Sep 7;8(9):e3033. doi: 10.1038/cddis.2017.424. Cell Death Dis. 2017. PMID: 28880262 Free PMC article.
-
Efficacy, Safety, and Cost of Therapy of the Traditional Chinese Medicine, Catalpol, in Patients Following Surgical Resection for Locally Advanced Colon Cancer.Med Sci Monit. 2018 May 15;24:3184-3192. doi: 10.12659/MSM.907569. Med Sci Monit. 2018. PMID: 29763415 Free PMC article. Clinical Trial.
-
Anti-inflammatory Effect of a Limonin Derivative In Vivo and Its Mechanisms in RAW264.7 Cells.Inflammation. 2023 Feb;46(1):190-201. doi: 10.1007/s10753-022-01722-0. Epub 2022 Aug 20. Inflammation. 2023. PMID: 35986873
References
-
- Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74–108. - PubMed
-
- Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ. Cancer statistics, 2008. CA Cancer J Clin. 2008;58:71–96. - PubMed
-
- Danese S, Mantovani A. Inflammatory bowel disease and intestinal cancer: a paradigm of the Yin-Yang interplay between inflammation and cancer. Oncogene. 2010;29:3313–3323. - PubMed
-
- Vakkila J, Lotze MT. Inflammation and necrosis promote tumour growth. Nat Rev Immunol. 2004;4:641–648. - PubMed
-
- Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow? Lancet. 2001;357:539–545. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical